Browsing by Author "Al-Dewik, Nader"

Now showing items 1-2 of 2

Association of single nucleotide polymorphisms with dyslipidemia and risk of metabolic disorders in the State of Qatar

Al-Sharshani, Dalal; Velayutham, Dinesh; Samara, Muthanna; Gazal, Reham; Al Haj Zen, Ayman; Ismail, Mohamed A.; Ahmed, Mahmoud; Nasrallah, Gheyath; Younes, Salma; Rizk, Nasser; Hammuda, Sara; Qoronfleh, M. Walid; Farrell, Thomas; Zayed, Hatem; Abdulrouf, Palli Valapila; AlDweik, Manar; Silang, John Paul Ben; Rahhal, Alaa; Al-Jurf, Rana; Mahfouz, Ahmed; Salam, Amar; Al Rifai, Hilal; Al-Dewik, Nader I.... more authors ... less authors ( Wiley-Blackwell , 2023 , Article)
Background: Dyslipidemia is recognized as one of the risk factors of cardiovascular diseases (CVDs), type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD). Objective: The study aimed to investigate ...
Management of chronic myeloid leukaemia: current treatment options, challenges, and future strategies.

Younes, Salma; Ismail, Mohamed A; Al-Jurf, Rana; Ziyada, Ayah; Nasrallah, Gheyath K; Abdulrouf, Palli Valapila; Nagy, Mohamed; Zayed, Hatem; Farrell, Thomas; Sorio, Claudio; Morsi, Hisham; Qoronfleh, M Walid; Al-Dewik, Nader I... more authors ... less authors ( taylor and francis online , 2023 , Article)
Small molecule therapy is a critical component of targeted anticancer treatment, with tyrosine kinase inhibitors (TKIs) being the first compounds to treat the clonal Chronic Myelogenous Leukaemia (CML) translocation t ...